Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline

Daniela Melchiorri1, Tamarie Rocke2, Richard A Alm3

  • 1Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy; AMR Division, World Health Organization, Geneva, Switzerland.

The Lancet. Microbe
|October 25, 2024
PubMed

Insights

Antimicrobial resistance is a global health crisis, especially impacting young children. This study assesses new antibiotics against priority pathogens to address critical research and development gaps.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Antimicrobial resistance (AMR) is a significant global health threat, leading to millions of deaths annually.
  • Children under five are particularly vulnerable to AMR-related infections.
  • Current antimicrobial research and development (R&D) is insufficient compared to other major diseases.

Purpose of the Study:

  • To evaluate the efficacy of current and novel antibiotics against the World Health Organization's (WHO) 2024 bacterial priority pathogens list.
  • To identify gaps and guide future R&D efforts in the antibacterial drug pipeline.
  • To monitor evolving resistance patterns and emerging resistance mechanisms.

Main Methods:

  • Analysis of the global antibacterial clinical pipeline.
  • Evaluation of antibiotic activity against the 2024 WHO bacterial priority pathogens.
  • Trend analysis of R&D output and innovation potential.

Main Results:

  • The study highlights persistent gaps in the development of effective antibacterial drugs.
  • Evolving resistance patterns necessitate continuous evaluation of antibiotic efficacy.
  • The 2024 WHO priority pathogens list reflects current trends in bacterial infections and resistance.

Conclusions:

  • A comprehensive strategy is needed to combat AMR, including robust R&D.
  • Continuous monitoring and evaluation of the antibacterial pipeline are crucial.
  • Targeted antibiotic development against priority pathogens is essential for global health security.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
52.4K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
3